Literature DB >> 32206497

Recent strategies towards the surface modification of liposomes: an innovative approach for different clinical applications.

Amjad Ali Khan1, Khaled S Allemailem1,2, Saleh A Almatroodi2, Ahmed Almatroudi2, Arshad Husain Rahmani2.   

Abstract

Liposomes are very useful biocompatible tools used in diverse scientific disciplines, employed for the vehiculation and delivery of lipophilic, ampiphilic or hydrophilic compounds. Liposomes have gained the importance as drug carriers, as the drugs alone have limited targets, higher toxicity and develop resistance when used in higher doses. Conventional liposomes suffer from several drawbacks like encapsulation inefficiencies and partially controlled particle size. The surface chemistry of liposome technology started from simple conventional vesicles to second generation liposomes by modulating their lipid composition and surface with different ligands. Introduction of polyethylene glycol to lipid anchor was the first innovative strategy which increased circulation time, delayed clearance and opsonin resistance. PEGylated liposomes have been found to possess higher drug loading capacity up to 90% or more and some drugs like CPX-1 encapsuled in such liposomes have increased the disease control up to 73% patients suffering from colorectal cancer. The surface of liposomes have been further liganded with small molecules, vitamins, carbohydrates, peptides, proteins, antibodies, aptamers and enzymes. These advanced liposomes exhibit greater solubility, higher stability, long-circulating time and specific drug targeting properties. The immense utility and demand of surface modified liposomes in different areas have led their way to the modern market. In addition to this, the multi-drug carrier approach of targeted liposomes is an innovative method to overcome drug resistance while treating ceratin tumors. Presently, several second-generation liposomal formulations of different anticancer drugs are at various stages of clinical trials. This review article summarizes briefly the preparation of liposomes, strategies of disease targeting and exclusively the surface modifications with different entities and their clinical applications especially as drug delivery system. © King Abdulaziz City for Science and Technology 2020.

Entities:  

Keywords:  Aptasome; Enzymosome; Immunoliposome; Ligand-targeted liposomes; Liposomes

Year:  2020        PMID: 32206497      PMCID: PMC7062946          DOI: 10.1007/s13205-020-2144-3

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.406


  151 in total

1.  Efficient intracellular delivery of 5-fluorodeoxyuridine into colon cancer cells by targeted immunoliposomes.

Authors:  Gerben A Koning; Jan A A M Kamps; Gerrit L Scherphof
Journal:  Cancer Detect Prev       Date:  2002

2.  Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes.

Authors:  Liang Xu; Cheng-Cheng Huang; Weiqun Huang; Wen-Hua Tang; Antonina Rait; Yu Zhi Yin; Idalia Cruz; Lai-Man Xiang; Kathleen F Pirollo; Esther H Chang
Journal:  Mol Cancer Ther       Date:  2002-03       Impact factor: 6.261

3.  Studies of the spontaneous transfer of retinol from the retinol:retinol-binding protein complex to unilamellar liposomes.

Authors:  G Fex; G Johannesson
Journal:  Biochim Biophys Acta       Date:  1987-07-23

Review 4.  The expanding role of prodrugs in contemporary drug design and development.

Authors:  Jarkko Rautio; Nicholas A Meanwell; Li Di; Michael J Hageman
Journal:  Nat Rev Drug Discov       Date:  2018-04-27       Impact factor: 84.694

5.  Surface modification of liposomes by saccharides: vesicle size and stability of lactosyl liposomes studied by photon correlation spectroscopy.

Authors:  Junmin Zhu; Feng Yan; Zhongwu Guo; Roger E Marchant
Journal:  J Colloid Interface Sci       Date:  2005-09-15       Impact factor: 8.128

6.  RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo.

Authors:  Si Eun Baek; Kwang Hyun Lee; Yong Serk Park; Deok-Kun Oh; Sangtaek Oh; Keun-Sik Kim; Dong-Eun Kim
Journal:  J Control Release       Date:  2014-10-24       Impact factor: 9.776

7.  Enhanced delivery of synthetic oligonucleotides to human leukaemic cells by liposomes and immunoliposomes.

Authors:  D D Ma; A Q Wei
Journal:  Leuk Res       Date:  1996 Nov-Dec       Impact factor: 3.156

8.  Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study.

Authors:  G Lopez-Berestein; V Fainstein; R Hopfer; K Mehta; M P Sullivan; M Keating; M G Rosenblum; R Mehta; M Luna; E M Hersh
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

9.  Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo.

Authors:  Christopher P Leamon; Scott R Cooper; Gregory E Hardee
Journal:  Bioconjug Chem       Date:  2003 Jul-Aug       Impact factor: 4.774

Review 10.  Liposomal drug delivery systems: an update review.

Authors:  Abdus Samad; Y Sultana; M Aqil
Journal:  Curr Drug Deliv       Date:  2007-10       Impact factor: 2.565

View more
  12 in total

Review 1.  Recent advances in understanding oligonucleotide aptamers and their applications as therapeutic agents.

Authors:  Khaled S Allemailem; Ahmad Almatroudi; Mohammed A Alsahli; Ghaiyda Talal Basfar; Faris Alrumaihi; Arshad Husain Rahmani; Amjad Ali Khan
Journal:  3 Biotech       Date:  2020-11-24       Impact factor: 2.406

Review 2.  Inducible Tertiary Lymphoid Structures: Promise and Challenges for Translating a New Class of Immunotherapy.

Authors:  Shota Aoyama; Ryosuke Nakagawa; James J Mulé; Adam W Mailloux
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

Review 3.  Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery.

Authors:  Bethany Almeida; Okhil K Nag; Katherine E Rogers; James B Delehanty
Journal:  Molecules       Date:  2020-12-01       Impact factor: 4.411

Review 4.  Recent Advancements in Polymer/Liposome Assembly for Drug Delivery: From Surface Modifications to Hybrid Vesicles.

Authors:  Vincenzo De Leo; Francesco Milano; Angela Agostiano; Lucia Catucci
Journal:  Polymers (Basel)       Date:  2021-03-26       Impact factor: 4.329

Review 5.  Thrombolytic Agents: Nanocarriers in Targeted Release.

Authors:  Minghua Shen; Yujiao Wang; Fan Hu; Linwen Lv; Kui Chen; Gengmei Xing
Journal:  Molecules       Date:  2021-11-10       Impact factor: 4.411

Review 6.  Innovative Approaches of Engineering Tumor-Targeting Bacteria with Different Therapeutic Payloads to Fight Cancer: A Smart Strategy of Disease Management.

Authors:  Khaled S Allemailem
Journal:  Int J Nanomedicine       Date:  2021-12-16

7.  Liposome-Coated Arsenic-Manganese Complex for Magnetic Resonance Imaging-Guided Synergistic Therapy Against Carcinoma.

Authors:  Zhexiu Jin; Xue Yi; Jingjing Yang; Meili Zhou; Peifu Wu; Gen Yan
Journal:  Int J Nanomedicine       Date:  2021-06-01

Review 8.  SARS-CoV-2 and its new variants: a comprehensive review on nanotechnological application insights into potential approaches.

Authors:  Ramalingam Karthik Raja; Phuong Nguyen-Tri; Govindasamy Balasubramani; Arun Alagarsamy; Selcuk Hazir; Safa Ladhari; Alireza Saidi; Arivalagan Pugazhendhi; Arulandhu Anthoni Samy
Journal:  Appl Nanosci       Date:  2021-06-10       Impact factor: 3.869

Review 9.  Optimizing use of theranostic nanoparticles as a life-saving strategy for treating COVID-19 patients.

Authors:  Rasha Itani; Mansour Tobaiqy; Achraf Al Faraj
Journal:  Theranostics       Date:  2020-05-01       Impact factor: 11.556

Review 10.  Endoplasmic Reticulum Stress Provocation by Different Nanoparticles: An Innovative Approach to Manage the Cancer and Other Common Diseases.

Authors:  Amjad Ali Khan; Khaled S Allemailem; Ahmad Almatroudi; Saleh A Almatroodi; Ali Mahzari; Mohammed A Alsahli; Arshad Husain Rahmani
Journal:  Molecules       Date:  2020-11-16       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.